Venezuela Pharmaceuticals & Healthcare Report Q1 2013 - New Report Available
BMI View: High inflation, currency devaluation, import and foreign currency controls, as well as other structurally distorting policies in Venezuela have made the country's pharmaceutical market increasingly unattractive to multinationals. We expect the market to grow below nominal GDP levels between 2011 and 2015, and experience a contraction in real growth terms.
View full press release